Synthetic Futures

The synthetic biology sector is starting to gain steam, as humankind gets closer to achieving its long-held ambitions to hack into the natural world and make it work for us, and more investors start to arrive on the scene, according to Entrepreneur.

Developments in recent years have made it more likely that companies can use synthetic biology tools to produce new products like materials, biofuels, flavors, drugs, and fragrances, among others, Britt Wray writes.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.